Research Article
Fiberoptic Bronchoscopic Findings in Patients Suffering from Emerging Pulmonary Lophomoniasis: A First Registry-Based Clinical Study
Table 2
Demographic findings and characteristics of patients with Lophomonas infection referred to the INRCL according to the severity index.
| | Characteristic | Mild (%) | Moderate (%) | Severe (%) | Total |
| | Gender | | | | | | Male | 16 (50) | 10 (31.25) | 6 (12) | 32 | | Female | 10 (55.5) | 5 (27.7) | 3 (16.8) | 18 | | value | >0.05 | >0.05 | >0.05 | |
| | Age | | | | | | 20–30 | 0 (0) | 0 (0) | 1 (2) | 1 | | 31–40 | 1 (2) | 0 (0) | 1 (2) | 2 | | 41–50 | 3 (6) | 2 (4) | 2 (4) | 7 | | 51–60 | 3 (6) | 2 (4) | 2 (4) | 7 | | 61–70 | 9 (18) | 8 (16) | 2 (4) | 19 | | >70 | 10 (20) | 3 (6) | 1 (2) | 14 | | value | >0.05 | >0.05 | >0.05 | |
| | Underlying disease | | | | | | Diabetes mellitus | 1 (2) | 1 (2) | 3 (6) | 5 | | Cancer | 2 (4) | 1 (2) | 0 (0) | 3 | | Asthma | 0 (0) | 1 (2) | 1 (2) | 2 | | Cushing’s | 0 (0) | 1 (2) | 0 (0) | 1 | | Epilepsy | 1 (2) | 0 (0) | 0 (0) | 1 | | Hypertension | 1 (2) | 1 (2) | 1 (2) | 3 | | Rheumatoid arthritis | 0 (0) | 1 (2) | 0 (0) | 1 | | value | >0.05 | >0.05 | >0.05 | |
| | Comorbidity | | | | | | Tuberculosis | 2 (4) | 0 (0) | 0 (0) | 2 | | COVID-19 | 0 (0) | 0 (0) | 1 (2) | 1 | | value | >0.05 | >0.05 | >0.05 | |
| | Smoking status | | | | | | Yes | 7 (14) | 4 (8) | 3 (6) | 14 | | No | 19 (38) | 11 (22) | 6 (12) | 36 | | value | <0.05 | <0.05 | >0.05 | 50 |
|
|
|